The Journal of Organic Chemistry
Article
3.86 (s, 3H), 3.84 (s, 3H), 3.82 (s, 3H), 3.79 (s, 3H), 3.14 (dd, J =
16.3, 4.6 Hz, 1H), 3.07 (dd, J = 16.3, 6.9 Hz, 1H), 1.88−1.74 (m, 1H),
1.64−1.57 (m, 1H), 1.51−1.44 (m, 1H), 0.94 (d, J = 7.0 Hz, 3H), 0.90
(d, J = 7.0 Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ 197.9, 168.7,
163.7, 155.6, 147.8, 139.1, 130.4, 130.3, 113.8, 113.7, 100.8, 94.9, 56.4,
55.7, 55.3, 51.1, 47.7, 45.5, 44.2, 24.9, 23.2, 21.9; HRMS (ESI) m/z:
[M + H]+ Calcd for C24H32NO6 430.2230, Found 430.2230.
Hz, 1H), 7.47 (dd, J = 7.8, 7.8 Hz, 2H), 7.40 (dd, J = 9.1, 2.5 Hz, 1H),
6.68 (d, J = 9.1 Hz, 1H), 4.30−4.26 (m, 1H), 3.86 (s, 3H), 3.30 (dd, J
= 16.8, 4.3 Hz, 1H), 3.14 (dd, J = 16.8, 8.0 Hz, 1H), 1.36 (d, J = 6.4
Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ 198.5, 168.1, 148.7, 137.3,
137.0, 134.1, 133.3, 128.7, 128.1, 113.5, 111.5, 105.9, 51.6, 44.7, 44.4,
21.0; HRMS (ESI) m/z: [M + H]+ Calcd for C18H19BrNO3 376.0548,
Found 376.0549.
Methyl 4-Chloro-2-((4-oxo-4-phenylbutan-2-yl)amino)benzoate
(3j). Compound 3j was synthesized from methyl 2-amino-4-
chlorobenzoate (66.8 mg, 0.360 mmol) and (E)-1-phenylbut-2-en-1-
one (43.9 mg, 0.300 mmol) in 94% yield (93.9 mg, 0.283 mmol) as a
yellow solid. mp 176−177 °C. IR (neat): 3389 (w), 1676 (s), 1612 (s)
cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.96 (dd, J = 7.3, 1.6 Hz, 2H),
7.95 (br s, 1H), 7.82 (d, J = 8.5 Hz, 1H), 7.58 (td, J = 7.3, 1.6 Hz, 1H),
7.47 (dd, J = 7.3, 7.3 Hz, 2H), 6.76 (d, J = 2.0 Hz, 1H), 6.54 (dd, J =
8.5, 2.0 Hz, 1H), 4.27−4.23 (m, 1H), 3.84 (s, 3H), 3.31 (dd, J = 16.9,
4.4 Hz, 1H), 3.15 (dd, J = 16.9, 8.0 Hz, 1H), 1.37 (d, J = 6.4 Hz, 3H);
13C NMR (CDCl3, 100 MHz): δ 198.6, 168.2, 148.5, 137.1, 134.7,
Methyl 2-((1-(4-Bromophenyl)-5-methyl-1-oxohexan-3-yl)-
amino)-4,5-dimethoxybenzoate (3e). Compound 3e was synthesized
from methyl 2-amino-4,5-dimethoxybenzoate (76.0 mg, 0.360 mmol)
and (E)-1-(4-bromophenyl)-5-methylhex-2-en-1-one (80.2 mg, 0.300
mmol) in 87% yield (125.3 mg, 0.262 mmol) as a sticky oil. IR (neat):
1
3248 (w), 1686 (s), 1621 (s) cm−1; H NMR (CDCl3, 400 MHz): δ
7.78 (d, J = 8.5 Hz, 2H), 7.77 (br s, 1H), 7.58 (d, J = 8.5 Hz, 2H), 7.34
(s, 1H), 6.34 (s, 1H), 4.32−4.21 (m, 1H), 3.88 (s, 3H), 3.83 (s, 3H),
3.81 (s, 3H), 3.16 (dd, J = 16.3, 4.9 Hz, 1H), 3.11 (dd, J = 16.3, 6.6
Hz, 1H), 1.85−1.75 (m, 1H), 1.66−1.56 (m, 1H), 1.50−1.46 (m, 1H),
0.95 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3,
100 MHz): δ 198.6, 168.8, 155.5, 147.6, 139.3, 135.9, 132.0, 129.7,
128.5, 113.6, 101.0, 94.9, 56.4, 55.7, 51.2, 47.7, 45.5, 44.5, 24.9. 23.2,
21.9; HRMS (ESI) m/z: [M + H]+ Calcd for C23H29BrNO5 478.1229,
Found 478.1229.
133.4, 131.2, 128.7, 128.1, 119.3, 113.2, 111.0, 51.7, 44.8, 44.5, 21.0;
HRMS (ESI) m/z: [M + H]+ Calcd for C18H19ClNO3 332.1053,
Found 332.1054.
Methyl 5-Chloro-2-((5-methyl-1-oxo-1-phenylhexan-3-yl)amino)-
benzoate (3k). Compound 3k was synthesized from methyl 2-amino-
5-chlorobenzoate (66.8 mg, 0.360 mmol) and (E)-5-methyl-1-
phenylhex-2-en-1-one (56.5 mg, 0.300 mmol) in 80% yield (90.1
mg, 0.241 mmol) as a greenish oil. IR (neat): 3275 (w), 1655 (s),
Methyl 2-((1-(3-Chlorophenyl)-5-methyl-1-oxohexan-3-yl)-
amino)-4,5-dimethoxybenzoate (3f). Compound 3f was synthesized
from methyl 2-amino-4,5-dimethoxybenzoate (76.0 mg, 0.360 mmol)
and (E)-1-(3-chlorophenyl)-5-methylhex-2-en-1-one (66.8 mg, 0.300
mmol) in 90% yield (117.6 mg, 0.271 mmol) as a greenish oil. IR
1
1602 (s) cm−1; H NMR (CDCl3, 400 MHz): δ 7.99 (d, J = 2.3 Hz,
1
(neat): 3412 (w), 1673 (s), 1612(s) cm−1; H NMR (CDCl3, 400
1H), 7.92 (dd, J = 7.3, 1.5 Hz, 2H), 7.79 (br s, 1H), 7.55 (dd, J = 7.3,
7.3 Hz, 1H), 7.46 (dd, J = 7.8, 7.8 Hz, 2H), 7.38 (dd, J = 9.0, 2.3 Hz,
1H), 6.72 (d, J = 9.0 Hz, 1H), 4.33−4.22 (m, 1H), 3.84 (s, 3H), 3.20
(dd, J = 17.1, 4.6 Hz, 1H), 3.14 (dd, J = 17.1, 7.3 Hz, 1H), 1.87−1.75
(m, 1H), 1.62−1.47 (m, 2H), 0.95 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.6
Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ 198.8, 168.1, 149.2, 137.3,
134.0, 133.2, 132.5, 128.6, 128.0, 113.3, 111.3, 105.6, 51.6, 47.0, 45.0,
24.9, 23.2, 22.3, 21.8; HRMS (ESI) m/z: [M + H]+ Calcd for
C21H25ClNO3 374.1523, Found 374.1519.
MHz): δ 7.89 (s, 1H), 7.80 (d, J = 7.5 Hz, 1H), 7.53 (d, J = 7.8 Hz,
1H), 7.39 (dd, J = 7.8, 7.5 Hz, 1H), 7.34 (s, 1H), 6.36 (s, 1H), 4.27 (br
s, 1H), 3.89 (s, 3H), 3.84 (s, 3H), 3.81 (s, 3H), 3.22 (dd, J = 16.6, 4.6
Hz, 1H), 3.12 (dd, J = 16.6, 6.6 Hz, 1H), 1.85−1.75 (m, 1H), 1.66−
1.60 (m, 2H), 1.51−1.43 (m, 1H), 0.95 (d, J = 6.6 Hz, 3H), 0.93 (d, J
= 6.6 Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ 198.6, 169.1, 155.8,
147.9, 139.0, 135.3, 133.5, 130.3, 128.6, 128.5, 126.5, 114.0, 101.3,
95.1, 56.7, 56.0, 51.5, 47.8, 45.8, 45.0, 25.2, 23.5, 22.2; HRMS (ESI)
m/z: [M + H]+ Calcd for C23H29ClNO5 434.1734, Found 434.1732.
Methyl 2-((4-Oxo-4-phenylbutan-2-yl)amino)benzoate (3g).
Compound 3g was synthesized from methyl 2-aminobenzoate (54.4
mg, 0.360 mmol) and (E)-1-phenylbut-2-en-1-one (43.9 mg, 0.300
mmol) in 96% yield (85.9 mg, 0.289 mmol) as a greenish oil. IR
Methyl 4,5-Dimethoxy-2-((4-oxohexan-2-yl)amino)benzoate (3l).
Compound 3l was synthesized from methyl 2-amino-4,5-dimethox-
ybenzoate (76.0 mg, 0.360 mmol) and (E)-hex-4-en-3-one (34.3 μL,
0.300 mmol) in 92% yield (85.8 mg, 0.276 mmol) as an ivory solid.
1
mp 86−87 °C; IR (neat): 3078 (w), 1612 (s), 1566 (s) cm−1; H
1
(neat): 3356 (w), 1663 (s), 1633 (s) cm−1; H NMR (CDCl3, 400
NMR (CDCl3, 400 MHz): δ 7.66 (s, 1H), 7.36 (s, 1H), 6.27 (s, 1H),
4.13 (br s, 1H), 3.91 (s, 3H), 3.83 (s, 3H), 3.82 (s, 3H), 2.78 (dd, J =
16.1, 4.8 Hz, 1H), 2.56 (dd, J = 16.1, 7.3 Hz, 1H), 2.49−2.44 (m, 2H),
1.29 (d, J = 6.3 Hz, 3H), 1.04 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3,
100 MHz): δ 210.6, 168.8, 155.4, 147.3, 139.3, 113.5, 101.1, 95.0, 56.4,
55.8, 51.2, 49.3, 44.7, 37.4, 21.3, 7.5; HRMS (ESI) m/z: [M + H]+
Calcd for C16H24NO5 310.1654, Found 310.1648.
MHz): δ 8.00−7.95 (m, 3H), 7.92 (dd, J = 8.0, 1.5 Hz, 1H), 7.86 (br s,
1H), 7.57 (dd, J = 8.0, 8.0 Hz, 1H), 7.46 (dd, J = 7.7, 7.7 Hz, 2H), 6.78
(d, J = 8.0 Hz, 1H), 6.59 (dd, J = 7.7, 7.7 Hz, 1H), 4.39−4.28 (m, 1H),
3.80 (s, 3H), 3.35 (dd, J = 16.8, 3.9 Hz, 1H), 3.16 (dd, J = 16.8, 8.4
Hz, 1H), 1.36 (d, J = 6.3 Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ
198.8, 169.2, 149.9, 137.1, 134.8, 133.3, 131.9, 128.7, 128.2, 114.7,
111.7, 110.1, 51.4, 44.9, 44.3, 21.1; HRMS (ESI) m/z: [M + H]+ Calcd
for C18H20NO3 298.1443, Found 298.1443.
Representative Experimental Procedure for the One-Pot
Synthesis of 3-Aroyl-2-Substituted 4-Quinolones. 3-Benzoyl-
6,7-dimethoxy-2-methylquinolin-4(1H)-one (4a). In the glovebox,
methyl 2-amino-4,5-dimethoxybenzoate (1a) (76.0 mg, 0.360 mmol),
CuCl (1.50 mg, 0.0150 mmol), dppbz (6.70 mg, 0.0150 mmol), and
KOt-Bu (1.70 mg, 0.0150 mmol) were added to a vial (8 mL) charged
with a magnetic bar. The vial was sealed with a cap (phenolic open top
cap with gray PTFE/silicone) and taken out of the glovebox. The vial
was purged with N2 gas for 5 min. Toluene (0.7 mL) was added to the
mixture, which was allowed to premix for 10 min. Then, a solution of
(E)-1-phenylbut-2-en-1-one (2a) (43.9 mg, 0.300 mmol) in toluene
(0.8 mL) was added to the mixture, which was allowed to stir at room
temperature for 3 h. After that time, KOt-Bu (101 mg, 0.900 mmol)
was added, and the reaction was allowed to stir for an additional 1 h at
22 °C. In open air conditions, an aqueous solution of 6 N HCl (1.5
mL) was added to the resulting solution, which was allowed to stir for
1 h. The reaction was quenched by adding a saturated aqueous
solution of K2CO3 (2 mL) and was washed with CH2Cl2 (3 × 2 mL).
The organic layers were combined, dried over MgSO4, filtered, and
concentrated in vacuo. The crude product was purified by silica gel
column chromatography (MeOH:CH2Cl2 = 5:95) to afford the
desired product 4a (72.7 mg, 0.225 mmol, 75% yield) as a yellow solid.
Methyl 5-Methyl-2-((4-oxo-4-phenylbutan-2-yl)amino)benzoate
(3h). Compound 3h was synthesized from methyl 2-amino-5-
methylbenzoate (59.5 mg, 0.360 mmol) and (E)-1-phenylbut-2-en-1-
one (43.9 mg, 0.300 mmol) in 96% yield (90.0 mg, 0.289 mmol) as a
1
yellow oil. IR (neat): 3386 (w), 1673 (s), 1611 (s) cm−1; H NMR
(CDCl3, 400 MHz): δ 7.78 (d, J = 7.3 Hz, 2H), 7.57 (br s, 1H), 7.50
(br, 1H), 7.37 (dd, J = 7.4, 7.4 Hz, 1H), 7.27 (dd, J = 7.7, 7.7 Hz, 2H),
7.01 (dd, J = 8.5, 2.0 Hz, 1H), 6.56 (d, J = 8.5 Hz, 1H), 4.17−4.12 (m,
1H), 3.68 (s, 3H), 3.16 (dd, J = 16.7, 4.0 Hz, 1H), 2.95 (dd, J = 16.7,
8.3 Hz, 1H), 2.06 (s, 3H), 1.20 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3,
100 MHz): δ 198.7, 169.0, 147.9, 135.7, 133.0, 131.5, 128.5, 127.9,
123.5, 116.7, 111.7, 109.9, 51.1, 44.8, 44.3, 21.0, 19.9; HRMS (ESI)
m/z: [M + H]+ Calcd for C19H22NO3 312.1600, Found 312.1604.
Methyl 5-Bromo-2-((4-oxo-4-phenylbutan-2-yl)amino)benzoate
(3i). Compound 3i was synthesized from methyl 2-amino-5-
bromobenzoate (82.8 mg, 0.360 mmol) and (E)-1-phenylbut-2-en-1-
one (43.9 mg, 0.300 mmol) in 95% yield (107 mg, 0.284 mmol) as a
bright yellow solid. mp 155−156 °C. IR (neat): 3425 (w), 1683 (s),
1
1601 (s) cm−1; H NMR (CDCl3, 400 MHz): δ 8.01 (d, J = 2.5 Hz,
1H), 7.95 (d, J = 7.8 Hz, 2H), 7.84 (br s, 1H), 7.58 (dd, J = 7.4, 7.4
G
J. Org. Chem. XXXX, XXX, XXX−XXX